• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撤回:用一种新型强效溶瘤腺病毒对肿瘤细胞中的检查点激酶1进行选择性靶向作用

RETRACTED: Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus.

作者信息

Gao Qinglei, Zhou Jianfeng, Huang Xiaoyuan, Chen Gang, Ye Fei, Lu Yunping, Li Kanyan, Zhuang Liang, Huang Mei, Xu Gang, Wang Shxuan, Ma Ding

机构信息

Cancer Biology Research Center, TongJi Hospital, TongJi Medical School, Huazhong University of Science & Technology, WuHan, Hubei 430030, People's Republic of China.

Cancer Biology Research Center, TongJi Hospital, TongJi Medical School, Huazhong University of Science & Technology, WuHan, Hubei 430030, People's Republic of China.

出版信息

Mol Ther. 2006 May;13(5):928-937. doi: 10.1016/j.ymthe.2005.12.009. Epub 2006 Feb 3.

DOI:10.1016/j.ymthe.2005.12.009
PMID:16459149
Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the editor-in-chief. Similarities were reported between images in this article and an article in Clinical Cancer Research (Zhou et al., 2005, Clin. Cancer Res. 11, 8431-8440, https://10.1158/1078-0432.CCR-05-1085). Q.J., J.Z., X.H., G.C., Y.L., K.L., L.Z., and D.M. were all authors of the Clinical Cancer Research paper as well. These concerns were initially reported in a Pubpeer thread (https://pubpeer.com/publications/FF881782FF5AFD316D42E0C0F00766). Image analysis performed by the editorial office confirmed findings of image recycling in Figures 2A and 3B of the Molecular Therapy article. This reuse (and in part misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system.

摘要

本文已被撤回

请参阅爱思唯尔的文章撤回政策(http://www.elsevier.com/locate/withdrawalpolicy)。本文应主编要求被撤回。据报道,本文中的图像与《临床癌症研究》中的一篇文章(Zhou等人,2005年,《临床癌症研究》11卷,8431 - 8440页,https://10.1158/1078-‌0432.CCR-05-1085)存在相似之处。Q.J.、J.Z.、X.H.、G.C.、Y.L.、K.L.、L.Z.和D.M.也是《临床癌症研究》那篇论文的作者。这些问题最初在Pubpeer的一个帖子(https://pubpeer.com/publications/FF881782FF5AFD316D‌42E0C0F00766)中被报道。编辑部进行的图像分析证实了《分子疗法》文章图2A和图3B中存在图像重复使用的情况。这种未经适当归属的数据重复使用(以及部分错误表述)严重滥用了科学出版系统。

相似文献

1
RETRACTED: Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus.撤回:用一种新型强效溶瘤腺病毒对肿瘤细胞中的检查点激酶1进行选择性靶向作用
Mol Ther. 2006 May;13(5):928-937. doi: 10.1016/j.ymthe.2005.12.009. Epub 2006 Feb 3.
2
Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and tumor cell viability.新型溶瘤腺病毒选择性靶向肿瘤相关的polo样激酶1和肿瘤细胞活力。
Clin Cancer Res. 2005 Dec 1;11(23):8431-40. doi: 10.1158/1078-0432.CCR-05-1085.
3
RETRACTED: Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC).撤回:胰岛素样生长因子结合蛋白-7(IGFBP7):一种有前途的肝细胞癌(HCC)基因治疗药物。
Mol Ther. 2013 Apr;21(4):758-66. doi: 10.1038/mt.2012.282. Epub 2013 Jan 15.
4
An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.一种对视网膜母细胞瘤肿瘤抑制蛋白通路缺陷型肿瘤具有选择性的溶瘤腺病毒:对E1A、E2F-1启动子以及病毒复制的依赖性,以实现选择性和有效性。
Cancer Res. 2003 Apr 1;63(7):1490-9.
5
A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.一种肝细胞癌特异性腺病毒变体CV890,与阿霉素联合使用可消除远处的人类肝脏肿瘤。
Cancer Res. 2001 Sep 1;61(17):6428-36.
6
A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.一种新型高尔基体蛋白(GOLPH2)调控的溶瘤腺病毒在肝细胞癌中展现出强大的抗肿瘤功效。
Oncotarget. 2015 May 30;6(15):13564-78. doi: 10.18632/oncotarget.3769.
7
RETRACTED: Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity.撤回:经基因工程改造以表达三种治疗因子的神经干细胞介导慢性期中枢神经系统自身免疫性疾病的恢复。
Mol Ther. 2016 Aug;24(8):1456-1469. doi: 10.1038/mt.2016.104. Epub 2016 May 16.
8
RETRACTED: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically.撤回:SET1A与CUDR协同作用,通过表观遗传促进肝癌生长和肝细胞样干细胞恶性转化。
Mol Ther. 2016 Feb;24(2):261-275. doi: 10.1038/mt.2015.208. Epub 2015 Nov 19.
9
Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.通过双调控复制溶瘤腺病毒增强 SOCS3 对肝癌的 TRAIL 抗肿瘤作用。
Hum Gene Ther. 2011 Sep;22(9):1109-19. doi: 10.1089/hum.2010.219. Epub 2011 Apr 21.
10
Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.双调控溶瘤腺病毒对肝细胞癌具有增强的安全性并保留抗肿瘤疗效。
Clin Cancer Res. 2006 Nov 1;12(21):6523-31. doi: 10.1158/1078-0432.CCR-06-1491.

引用本文的文献

1
Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy.通过数字基因表达分析筛选胸膜间皮瘤的DNA损伤修复相关因子可加强接受铂类化疗患者的临床管理。
J Cancer. 2016 Sep 13;7(13):1915-1925. doi: 10.7150/jca.16390. eCollection 2016.
2
Hidden treasures in "ancient" microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue.“古老”微阵列中的隐藏宝藏:基因表达描绘了主要肺癌亚型和正常组织的生物学和潜在耐药途径。
Front Oncol. 2014 Sep 29;4:251. doi: 10.3389/fonc.2014.00251. eCollection 2014.
3
Co-abrogation of Chk1 and Chk2 by potent oncolytic adenovirus potentiates the antitumor efficacy of cisplatin or irradiation.
强效溶瘤腺病毒共抑制 Chk1 和 Chk2 增强顺铂或放疗的抗肿瘤疗效。
Cancer Gene Ther. 2014 May;21(5):209-17. doi: 10.1038/cgt.2014.20. Epub 2014 May 23.
4
A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKs.三种腺病毒载体胸苷激酶的抗肿瘤活性和毒性的系统比较。
PLoS One. 2014 Apr 10;9(4):e94050. doi: 10.1371/journal.pone.0094050. eCollection 2014.
5
Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.利用 DNA 损伤反应通路实现放射增敏的分子靶点和机制。
Future Oncol. 2013 Feb;9(2):219-33. doi: 10.2217/fon.12.185.
6
Overexpression of mitochondrial uncoupling protein 2 inhibits inflammatory cytokines and activates cell survival factors after cerebral ischemia.线粒体解偶联蛋白 2 的过表达可抑制脑缺血后的炎症细胞因子,并激活细胞存活因子。
PLoS One. 2012;7(2):e31739. doi: 10.1371/journal.pone.0031739. Epub 2012 Feb 14.
7
Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors.间质干细胞作为 CRAd 递送肿瘤的载体和扩增剂。
Mol Cancer. 2011 Nov 3;10:134. doi: 10.1186/1476-4598-10-134.
8
Intelligent design: combination therapy with oncolytic viruses.智能设计:溶瘤病毒联合治疗。
Mol Ther. 2010 Feb;18(2):251-63. doi: 10.1038/mt.2009.283. Epub 2009 Dec 22.
9
Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.LRIG1 的上调通过减弱表皮生长因子受体(EGFR)活性来抑制恶性胶质瘤细胞的生长。
J Neurooncol. 2009 Sep;94(2):183-94. doi: 10.1007/s11060-009-9836-1. Epub 2009 Mar 20.
10
Armed replicating adenoviruses for cancer virotherapy.用于癌症病毒疗法的武装复制腺病毒
Cancer Gene Ther. 2009 Jun;16(6):473-88. doi: 10.1038/cgt.2009.3. Epub 2009 Feb 6.